Key Points
- Foundation supporters Robert and Molly Hardie recently hosted a reception of thirty guests at their Nantucket home.
- Foundation Chairman Neal F. Kassell, MD, shared the technology’s current status and its potential for many disorders.
On August 8, long-time Foundation supporters Robert and Molly Hardie hosted a reception at their home in Nantucket to raise awareness for focused ultrasound. Foundation Chairman Neal F. Kassell, MD, addressed the gathering of thirty guests, sharing the technology’s current status and its potential for treating many disorders.
The event was a great opportunity to raise awareness and advance the adoption of focused ultrasound more quickly.
Robert and Molly Hardie first became involved with the Foundation in 2015, when they helped to fund an early-stage study investigating the use of focused ultrasound to enhance immunotherapy for melanoma brain metastases.
Molly joined the Foundation’s Council in January of this year. At the time, she said, “I am delighted to join the Council and to use my medical degree to help advance this technology. Robert and I have found the work that the Foundation is doing in cancer immunotherapy to be quite exciting. In addition, we are interested in how focused ultrasound can penetrate the blood-brain barrier and be utilized therapeutically in neurodegenerative and psychiatric diseases. Focused ultrasound shows great promise to extend survival and improve quality of life for patients in the future.”
“We extend our gratitude to Robert and Molly for their support and for hosting such an engaging event last week,” said Dr. Kassell. “The attendees asked meaningful questions, and we were able to share the power of focused ultrasound with a new audience.”